Spruce Biosciences, Inc. (SPRB)
Last updated: 2026-10-21 04:13:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Spruce Biosciences, Inc. (SPRB) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $41.34, with a market capitalization of $113.95M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $38.06 to $154.95. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$113.95M | |
$40.57 | |
$2,670.00 | |
$4.28 | |
$40.40 | |
48.69K | |
79.40K | |
-- | |
$154.95 | |
$38.06 | |
-- | |
-- |
Spruce Biosciences, Inc. (SPRB) Latest Closing Stock Price
Spruce Biosciences, Inc. (SPRB) last closed at $40.40 as of 2026-10-20 23:58:00, unchanged from the previous close of $40.40.
During the latest regular trading session, SPRB traded between $4.28 and $2,670.00, with a volume of 48.69K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Spruce Biosciences, Inc. (SPRB) 7-Day Stock Price Change
Over the past seven days, Spruce Biosciences, Inc. (SPRB) moved from $44.05 to $41.34, representing a decline of 6.16% ($2.71).
The stock traded between $38.06 and $45.04 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 84.59 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
SPRB 52-Week Price Position
Position in Range: 2.8%
SPRB is currently trading at $41.34, placing it 2.8% of the way from its 52-week low of $38.06 to its 52-week high of $154.95. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Spruce Biosciences, Inc. (SPRB)?
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company develops biologics and small-molecule product candidates aimed at addressing diseases with unmet medical needs and limited or no approved therapies. Its product candidate, TA-ERT for the treatment of Mucopolysaccharidosis Type IIIB (MPS IIIB), is a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase (rhNAGLU) intended as an enzyme replacement therapy for patients who lack rhNAGLU enzyme activity. TA-ERT is designed to restore rhNAGLU enzyme activity in the central nervous system following intracerebroventricular injection and promote clearance of heparan sulfate in the brain.
Spruce Biosciences, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 8 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Spruce Biosciences, Inc. (SPRB) Stock on MEXC
Eligible investors can buy real shares of Spruce Biosciences, Inc. (SPRB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Spruce Biosciences, Inc. (SPRB) stock price today?
2.Is SPRB stock going up or down today?
3.What is SPRB pre-market price?
4.What is SPRB after-hours price?
5.Is SPRB stock trading now?
6.Where does SPRB sit relative to its 52-week high and low?
7.What sector is Spruce Biosciences, Inc. in?
8.What is Spruce Biosciences, Inc.'s market capitalization and where is it listed?
9.How is SPRB valued in terms of P/E ratio and EPS?
10.Does Spruce Biosciences, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
SPRB Stock Calculator
Estimate the value between SPRB shares and USD.
SPRB Shares to USD
1.00 SPRB shares = 41.338 USD
Calculations are estimates based on the latest available price and are for reference only.


